AstraZeneca plc ADR

Historical 13F Holders

Symbol
AZN
CUSIP
046353108
All holders as of
Q1 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1,274 501 M $37.3 B
2024 Q4 1,249 514 M $33.7 B
2024 Q3 1,277 505 M $39.4 B
2024 Q2 1,256 516 M $40.3 B
2024 Q1 1,188 531 M $36.0 B
2023 Q4 1,173 519 M $35.0 B
2023 Q3 1,125 497 M $33.8 B
2023 Q2 1,151 503 M $37.0 B
2023 Q1 1,110 518 M $35.7 B
2022 Q4 1,119 514 M $35.3 B
2022 Q3 1,026 521 M $28.6 B
2022 Q2 1,063 529 M $35.0 B
2022 Q1 1,027 517 M $34.3 B
2021 Q4 1,013 505 M $29.4 B
2021 Q3 974 517 M $31.1 B
2021 Q2 828 434 M $26.1 B
2021 Q1 810 411 M $20.5 B
2020 Q4 847 400 M $20.1 B
2020 Q3 772 408 M $22.4 B
2020 Q2 720 428 M $22.7 B
2020 Q1 638 442 M $19.8 B
2019 Q4 678 447 M $22.3 B
2019 Q3 592 458 M $20.4 B
2019 Q2 604 461 M $19.1 B
2019 Q1 598 478 M $19.3 B
2018 Q4 594 466 M $17.7 B
2018 Q3 589 440 M $17.5 B
2018 Q2 573 413 M $14.5 B
2018 Q1 563 398 M $13.9 B
2017 Q4 546 385 M $13.4 B
2017 Q3 499 375 M $12.7 B
2017 Q2 536 361 M $12.3 B
2017 Q1 517 358 M $11.2 B
2016 Q4 501 320 M $8.74 B
2016 Q3 488 329 M $10.8 B
2016 Q2 435 281 M $8.48 B
2016 Q1 411 254 M $7.15 B
2015 Q4 422 222 M $7.52 B
2015 Q3 403 204 M $6.48 B
2015 Q2 405 98.3 M $6.24 B
2015 Q1 419 89.8 M $6.16 B
2014 Q4 462 89.5 M $6.33 B
2014 Q3 478 76.3 M $5.45 B
2014 Q2 485 96.9 M $7.21 B
2014 Q1 420 116 M $7.59 B